The company has received approval from SEBI to launch its IPO and aims to raise over ₹11,000 crore through this.

Nithin Kamath, CEO of Zerodha, explained why the trading platform hasn't gone public, focusing on risk diversification and ...

BioAge Labs (BIOA), which is developing a drug to augment popular weight-loss medications such as Wegovy and Zepbound, has upsized its proposed IPO. Read more here.

Before that, VC firm Atomico Partners fully exited Truecaller when it sold its remaining 2.51% stake in the company in ...

Upstream Bio plans to IPO to advance its Phase 2 drug candidate, verekitug, for severe asthma and chronic rhinosinusitis.

Glottis, a Chennai-based logistics service provider, plans to raise Rs 450-500 crore through an IPO. The offering includes a ...

With an eye on increasing the adoption of EVs, the Karnataka government reportedly plans to offer incentives and cut taxes on ...

Spanish bread and pastry maker Europastry SA is planning to kick off its initial public offering in Spain, according to ...

Smartsheet announced Tuesday that it agreed to be acquired by private equity companies Blackstone and Vista Equity Partners ...

Nikunj Dalmia told about Swiggy IPO that Swiggy is a big brand and people know this company and are able to connect with them ...

BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently ...

FBS Global Limited FBGL IPO will take place September, 26 on the NASDAQ exchange under the ticker FBGL. The company is ...